CD44 and glioblastoma: Further in silico analysis of TIMER2 glioblastoma patient data sets also suggested that RCN3 showed a positive correlation with stemness marker CD44 and a negative correlation with differentiation markers such as ID4, MAP2, and NTRK5 (Supplementary Figure S4D).